130 related articles for article (PubMed ID: 23506500)
1. Clinical management of the cardiovascular failure in sepsis.
De Backer D; Scolletta S
Curr Vasc Pharmacol; 2013 Mar; 11(2):222-42. PubMed ID: 23506500
[TBL] [Abstract][Full Text] [Related]
2. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
3. The heart in sepsis: from basic mechanisms to clinical management.
Rudiger A; Singer M
Curr Vasc Pharmacol; 2013 Mar; 11(2):187-95. PubMed ID: 23506497
[TBL] [Abstract][Full Text] [Related]
4. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin in sepsis and septic shock.
Kampmeier TG; Rehberg S; Westphal M; Lange M
Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
[TBL] [Abstract][Full Text] [Related]
6. Vasopressors and Inotropes in Sepsis.
Stratton L; Berlin DA; Arbo JE
Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive drugs for vasodilatory shock in ICU.
Holmes CL; Walley KR
Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
[TBL] [Abstract][Full Text] [Related]
8. Perioperative treatment of patients with sepsis.
Ibsen M; Perner A
Curr Opin Anaesthesiol; 2013 Jun; 26(3):348-53. PubMed ID: 23474806
[TBL] [Abstract][Full Text] [Related]
9. Treatment of shock.
De Backer D
Acta Clin Belg; 2011; 66(6):438-42. PubMed ID: 22338308
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive drugs and the gut: is there anything new?
Woolsey CA; Coopersmith CM
Curr Opin Crit Care; 2006 Apr; 12(2):155-9. PubMed ID: 16543793
[TBL] [Abstract][Full Text] [Related]
11. Treatment of heart failure with preserved systolic function.
de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
[TBL] [Abstract][Full Text] [Related]
12. [Effect of catecholamines on splanchnic perfusion in sepsis].
Hernández G; Tomicic V
Rev Med Chil; 1999 Jun; 127(6):719-27. PubMed ID: 10513083
[TBL] [Abstract][Full Text] [Related]
13. Is it time to reposition vasopressors and inotropes in sepsis?
Rudis MI; Basha MA; Zarowitz BJ
Crit Care Med; 1996 Mar; 24(3):525-37. PubMed ID: 8625645
[TBL] [Abstract][Full Text] [Related]
14. Role of levosimendan in sepsis and septic shock.
Pinto BB; Rehberg S; Ertmer C; Westphal M
Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
16. [Inotropic agents].
Sasayama S
Nihon Rinsho; 2003 May; 61(5):807-14. PubMed ID: 12755007
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of inodilators.
Dei Cas L; Metra M; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
[TBL] [Abstract][Full Text] [Related]
18. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
[TBL] [Abstract][Full Text] [Related]
19. Inotrope and vasopressor therapy of septic shock.
Hollenberg SM
Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253
[TBL] [Abstract][Full Text] [Related]
20. [New cardiotonic/inodilator agents: energetic aspects].
Hasenfuss G
Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
